MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling (Q27851406)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
scientific article

    Statements

    MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling (English)
    Jeffrey A Engelman
    0 references
    Kreshnik Zejnullahu
    0 references
    Youngchul Song
    0 references
    Courtney Hyland
    0 references
    Joon Oh Park
    0 references
    Neal Lindeman
    0 references
    Christopher-Michael Gale
    0 references
    Xiaojun Zhao
    0 references
    James Christensen
    0 references
    Takayuki Kosaka
    0 references
    Alison J Holmes
    0 references
    Andrew M Rogers
    0 references
    Charles Lee
    0 references
    Bruce E Johnson
    0 references
    18 May 2007
    0 references
    0 references
    316
    0 references
    5827
    0 references
    1039-43
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit